Back Pain Doctor
De Quervain Tenosynovitis
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
De Quervain tenosynovitis affects the tendons that move the thumb away from the hand. Pain is usually felt over the thumb side of the wrist and can be aggravated by lifting, twisting, gripping or repetitive thumb use.
It is common in people who suddenly increase hand load, including new parents, manual workers, gym users and people doing repetitive gripping tasks. The diagnosis is usually clinical, although ultrasound may be useful when the diagnosis is uncertain or an injection is being considered.
Management involves reducing the sharpest aggravating loads while maintaining useful hand function. Splinting, hand therapy and selected image-guided injection can be considered depending on severity and response.
Common symptoms
- Pain on the thumb side of the wrist
- Pain with lifting, gripping, twisting or thumb movement
- Tenderness over the radial wrist tendons
- Symptoms with caring for infants, manual work, gym loading or racquet sports
Commonly seen in
Evidence for twelve treatment options in de quervain tenosynovitis
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Loading is the treatment, and the trials say adjuncts add little to it. A living network meta-analysis of 68 randomised trials across Achilles and patellar tendinopathy and gluteal tendinopathy found no convincing evidence that any adjunct, alone or added to exercise, beats exercise by itself, and recommended exercise alone for at least three months before an adjunct is considered (Challoumas, Sports Med Open 2023). A meta-analysis of 110 studies and 3,953 patients found greater effect where the programme added external load rather than body weight alone, and where sessions were less frequent than daily, allowing recovery (Pavlova, Br J Sports Med 2023). A 204-study synthesis found exercise safe, beneficial and acceptable to patients, with no clear superiority for the eccentric-only protocols long treated as standard (Cooper, Health Technol Assess 2023).
Pairing reviewed 2026-09-02.
Where it fits
This is the plan, not the preliminary. Expect a programme measured in months rather than weeks, with load progressed against your symptoms. Anything else offered here is an adjunct to it, and the evidence for adding one before three months of proper loading is weak.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. No study in this condition
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
Searched 7 November 2026 (PubMed: trigger point, dry needling, wet needling, trigger point injection, myofascial or intramuscular stimulation with de Quervain, first dorsal compartment or radial styloid tenosynovitis, 11 records; and a randomised-trial and systematic-review pass). No trial or series has injected or needled a muscle trigger point in de Quervain tenosynovitis. The only needling reports are single cases: ultrasound-guided dry needling of forearm muscles in a woman whose pain was complex regional pain syndrome presenting as de Quervain's after failed surgery (Vas, Pain Physician 2016), and acupuncture as one part of a multimodal program (Howell, J Can Chiropr Assoc 2012). A review of forearm muscle pain lists de Quervain's among the conditions that brachioradialis trigger points can mimic (Kim, Korean J Pain 2025). The studied injection for this condition is cortisone into the tendon sheath, which sits in the guided injection row.
Pairing reviewed 2026-11-07.
Where it fits
The problem is the tendon sheath at the wrist, and a sheath injection (see guided injection) and splinting are the established options. A trigger point injection would be considered only where a tender forearm-muscle band is found to be causing or adding to the pain.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Worth discussing
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
Multiple subcompartments are present in about half of wrists, and a missed subcompartment is a common reason an injection fails; ultrasound-guided injection gave at least partial resolution in 97% at six weeks (McDermott, Clin Orthop Relat Res 2012). Against that, a propensity-matched study of 396 hands found guidance did not reduce reintervention rates (Kim, Plast Reconstr Surg 2026).
Pairing reviewed 2026-08-30.
Where it fits
Reasonable where a first injection has failed, since a separate subcompartment is the usual explanation.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. One small trial, no sham arm
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Searched for shockwave in de Quervain's by device type: 14 records, and a randomised-trial pass that returned nothing indexed as a trial. The one study that can be read in full randomised 60 people to five sessions of shockwave or to high-intensity laser, with no sham or untreated group. Pain at rest fell from 8 to 1 out of 10 at three months in both groups and hand function improved equally, with pressure tenderness improving more after laser (Karakuzu Güngör, Turk J Phys Med Rehabil 2024). The paper does not use the word radial; it names a pressure-wave device and gives the dose in bar, which is how radial devices are dosed. A network meta-analysis of 14 randomised trials of non-surgical treatment found shockwave better than placebo for pain in the first six weeks and ranked it first to six months, without stating the device type, and its authors still place it second to a cortisone injection with a short period of splinting (Chong, J Hand Surg Am 2024). A review of shockwave in hand conditions found two de Quervain's studies, better than sham and no different from a cortisone injection, and graded the evidence C (Al-Mousllie, GMS Interdiscip Plast Reconstr Surg DGPW 2025). Pooled with trigger finger trials, the advantage over sham was not statistically significant and did not last beyond four weeks (Zhang, Front Physiol 2026).
Pairing reviewed 2026-10-09.
Where it fits
Can be discussed for de Quervain's that has not settled with splinting and activity change, particularly for someone who wants to avoid an injection. A cortisone injection with a short period of splinting remains the better-established treatment, and the shockwave evidence is small and short-term. The tendons here lie just under the skin, which suits the radial form.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. No trial names the focused form
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Searched for shockwave in de Quervain's by device type: 14 records, none of which states that a focused device was used at this site. The one trial that can be read in full used a pressure-wave device dosed in bar, the radial type: 60 people, shockwave equal to high-intensity laser at three months, no sham group (Karakuzu Güngör, Turk J Phys Med Rehabil 2024). The pooled analyses that find shockwave better than placebo in the short term do not report which device the trials used (Chong, J Hand Surg Am 2024). In a meta-analysis that mixed de Quervain's with trigger finger, the focused trials showed no significant reduction in pain (difference -1.27 points, 95% CI -4.08 to 1.53) while the radial trials did (-1.30 points, 95% CI -1.84 to -0.75), with no significant difference between the two forms (Zhang, Front Physiol 2026).
Pairing reviewed 2026-10-09.
Where it fits
Where shockwave is tried for de Quervain's, the radial form is the one with a trial behind it and it suits tendons this close to the skin. Focused shockwave can be discussed on the same reasoning, with the absence of trials naming it explained.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Matched cortisone in small trials
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
Tested against a cortisone injection in three small comparisons, and not against a dummy injection. In a randomised open-label trial of 86 people, ultrasound-guided PRP into the first extensor compartment was judged equivalent to triamcinolone for pain: cortisone was ahead at one week for pain and at one and four weeks for hand function, and the two were level by twelve weeks (Chowley, J Hand Surg Asian Pac Vol 2025). In 60 people randomised to one injection of either, there was no difference between them at any point to a year, with no complications after PRP and skin thinning, loss of pigment or a pain flare in 8 of 30 after cortisone (Kumar, J Wrist Surg 2022). In 40 people cortisone was better at two weeks and PRP at six months (Ashour, Cureus 2024). The contrary reading comes from a network meta-analysis of 14 randomised trials: PRP on its own was no better than placebo for pain in the first six weeks, though it and cortisone both held their pain relief at a year, and the authors keep a cortisone injection with a short period of splinting as the main treatment (Chong, J Hand Surg Am 2024). An uncontrolled series of 67 people given PRP with an anti-inflammatory tablet reported 85% reaching low pain at three weeks, less often in people with diabetes (Iqbal, Cureus 2025).
Pairing reviewed 2026-10-09.
Where it fits
An option that can be discussed where splinting and activity change have not been enough and a cortisone injection has already been tried or is best avoided, for example because of the risk of skin thinning or colour change at the wrist. Cortisone works faster in the first few weeks and remains the better-established injection. If used, PRP is placed around the tendons in the first compartment under ultrasound guidance.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Plausible: no studies
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No clinical study of prolotherapy in de Quervain tenosynovitis was found. PubMed searches on 13 October 2026 (prolotherapy, dextrose, hypertonic glucose or hyperosmolar with de Quervain, first dorsal compartment, radial styloid or wrist tenosynovitis) returned two records: a review of upper-limb tendon injection technique that reports no prolotherapy outcomes in this condition (Silva, Skeletal Radiol 2022), and a single case of nerve hydrodissection at the wrist, which is a different condition. Passes restricted to randomised trials and to systematic reviews or meta-analyses found nothing in this condition.
Pairing reviewed 2026-10-13.
Where it fits
Can be discussed where pain persists after splinting, activity change and a cortisone injection into the tendon sheath, with the absence of studies explained.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used for tendons
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Trialled as an add-on at this tendon sheath, but not offered here. A randomised trial of 75 people compared ultrasound-guided cortisone alone, cortisone followed by saline, and cortisone followed by low-molecular-weight hyaluronic acid. At six months the hyaluronic acid group had far less disability (quickDASH 26 against 51 in both other groups) and fewer recurrences (Orlandi, Eur Radiol 2014). A cadaver study of eighteen wrists found hyaluronic acid cut friction between the thumb tendons and the overlying retinaculum by 18.7% (Rotem, J Wrist Surg 2025).
Pairing reviewed 2026-10-05.
Where it fits
Not offered for this problem. Hyaluronic acid is considered only for a problem inside a joint, and de Quervain's is a tendon sheath problem.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Nerve mimic, case reports
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
Searched at this site, and what the search returns is about a nerve rather than the tendon sheath. No study tests a series of small dextrose injections just under the skin for de Quervain's. What it does return is the superficial branch of the radial nerve, which crosses the same patch of skin over the radial styloid and can mimic the condition (Wartenberg's syndrome). That nerve has been treated with dilute dextrose twice, both times by hydrodissection rather than by this technique: ten weekly sessions of ultrasound-guided 5% dextrose in a woman whose nerve was snapping over the radial styloid five years after a scaphoid fracture took her pain from 8 to 0 out of 10 and restored thumb extension strength, with nerve conduction returning to normal (Yoon, Diagnostics 2026), and a second case gave lasting relief where nerve conduction studies had been normal (Maroc, Cureus 2025). A cadaveric study of 21 arms showed ultrasound can reach every segment of that nerve, but fluid placed under the fascia reached the layer just beneath the skin - where this treatment works - in only 57% of arms (Meng, Muscle Nerve 2014).
Pairing reviewed 2026-09-28.
Where it fits
Considered only where examination finds tender, hypersensitive skin over the radial side of the wrist rather than pain along the tendons themselves. If the numbness or tingling pattern fits the nerve rather than the tendon sheath, that changes the diagnosis, and hydrodissection of the nerve is the better-described option.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. No controlled trials
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Direct evidence in de Quervain's, and none of it controlled. In 95 people with ultrasound-confirmed de Quervain's tenosynovitis, ultrasound-guided hydrodissection of the first extensor compartment lowered average pain from 7.7 to 1.7 out of 10 within two months, and 90 of the 95 improved; the five who did not all had a septum dividing the compartment and went on to surgery (Vita, JPRAS Open 2024). Note what was injected and where: the fluid goes around the tendons where they pass through the first dorsal compartment of the wrist, lifting them off the tight sheath. That is the same fluid-separation technique used at a nerve, applied to a tendon. There was no control group and no randomised trial, so how much of the improvement is the injection rather than time is not established.
Pairing reviewed 2026-09-08.
Where it fits
Reasonable to discuss where a corticosteroid injection is unwanted or has not held. Worth knowing beforehand that a divided compartment on ultrasound predicts a poorer response and may point towards surgical review.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other elbow, wrist & hand conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Related articles
Shorter articles that answer the questions patients ask most often about this.
- De Quervain Tenosynovitis: What Helps Thumb-Side Wrist Pain?De Quervain tenosynovitis causes thumb-side wrist pain. Learn when activity changes, splinting or injection may help and when to seek review in Brisbane.
- Wrist Pain: Exploring the Causes, Symptoms, and Treatment OptionsFractures, sprains, osteoarthritis, rheumatoid arthritis and carpal tunnel syndrome all cause wrist pain. How each is distinguished and managed.
Frequently asked questions
Is De Quervain tenosynovitis a tendon problem?
What usually helps first?
Does it always need surgery?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment